Selective serotonin reuptake inhibitors vs tricyclic antidepressants (TCAs)
Efficacy as a dichotomous outcome · patients with cancer and depression
It is very uncertain whether selective serotonin reuptake inhibitors (SSRIs) changes efficacy as a dichotomous outcome compared with tricyclic antidepressants (TCAs) (very low certainty).
1 finding from 1 review
- Antidepressants for the treatment of depression in people with cancer 2023 · Cochrane Headline outcomes onlyRR 1.12 studies · 199 participantsVery low